Fibromyalgia diagnosis: symptoms, tests and next steps
By Vye Health editorial team
Reviewed by Matt Vail, Co-Founder & CEO
Published . Updated . Last reviewed .
A fibromyalgia diagnosis is made from a pattern of widespread pain and symptoms such as fatigue, unrefreshing sleep, and trouble thinking. There is no single confirming blood test or scan. A clinician reviews your history, examines you, and checks for other explanations. The 2016 diagnostic criteria also allow fibromyalgia to be diagnosed alongside another illness, rather than treating the two as mutually exclusive.
What is fibromyalgia, and who does it affect?
Fibromyalgia is a long-term condition that affects how pain is processed. Pain is real even when routine tests do not show inflammation or tissue damage. Fatigue, poor sleep, and difficulty concentrating often accompany the pain. The CDC says it affects millions of people in the United States and is more common in adults and women, though children can develop it too.
A headache, digestive symptoms, or jaw pain may also be part of the picture. None of these symptoms alone identifies fibromyalgia. Tell your clinician about the full pattern, including symptoms that seem unrelated to pain.
Why can a fibromyalgia diagnosis take so long?
Pain, sleep problems, and fatigue overlap with many other conditions. People may see several clinicians, each evaluating a different part of the story. A normal test can help answer one question without explaining why you still feel unwell. The next step is a clear follow-up plan, not assuming that normal tests end the workup.
An international patient survey published in 2010 found long diagnostic journeys and difficulty communicating symptoms. It was an older, industry-funded survey of people already diagnosed, so it cannot tell a reader how long diagnosis will take today. It does support a practical point: a short written history can help a clinician see symptoms together.
Primary care can start that assessment. A rheumatologist may help when inflammatory or autoimmune disease is a concern; other referrals should answer a specific question. Ask who will coordinate the findings so you do not have to rebuild the whole story at every appointment.
What does a fibromyalgia diagnosis involve?
The 2016 criteria combine pain location, symptom severity, and duration. They do not rely on the older tender-point exam alone. A clinician still needs to assess other possible illnesses. A symptom questionnaire can help organize the visit, but it should not replace that assessment.
| Part of the assessment | What the 2016 criteria consider |
|---|---|
| Pain and symptom scores | A widespread pain index of at least 7 with a symptom severity score of at least 5, or a pain index of 4 to 6 with a severity score of at least 9 |
| Pain distribution | Pain in at least 4 of 5 body regions; jaw, chest, and abdominal pain do not count toward this region rule |
| Duration | Symptoms generally present for at least 3 months |
| Other diagnoses | Another illness does not rule out fibromyalgia, and fibromyalgia does not rule out another illness |
The pain index counts painful areas during the past week. The severity score covers fatigue, waking unrefreshed, cognitive symptoms, and several other symptoms. These are tools for the clinician to interpret with you, not scores you need to memorize.
Tests are chosen for the question being asked. For example, a clinician may look for another cause of fatigue or evidence of inflammatory disease. Ask what a result would change before paying for a large panel marketed as a fibromyalgia test. Our lab-results glossary explains why a result inside or outside a reference range is only part of the picture.
What treatments have evidence behind them?
The EULAR recommendations, published online in 2016 and in print in 2017, recommend education and non-drug care first, followed by options matched to the symptoms that matter most. Exercise was the only therapy with a strong recommendation in that guideline. Most other treatments had modest effects, so treatment should be reviewed against goals you choose together.
| Option | What to discuss with a clinician | Limits and tradeoffs |
|---|---|---|
| Aerobic or strengthening activity | A starting level that fits your abilities and a plan for symptom flares | Pain can increase initially; another condition may change what is appropriate |
| Cognitive behavioral therapy | Skills for coping with pain, sleep disruption, and the effects of illness | It is support for living with symptoms, not a claim that the pain is imagined |
| Medicines for pain or sleep | The symptom being targeted, a review date, and a stopping plan | Benefits vary, and side effects or interactions may outweigh them |
| Other non-drug options | Whether an option such as hydrotherapy or meditative movement fits your needs | EULAR's support is weaker than for exercise |
Activity advice needs particular care if you also have ME/CFS and delayed crashes after exertion. A clinician should account for both conditions. A general fibromyalgia exercise recommendation should not override ME/CFS guidance against fixed increases in activity.
Medicines are individual decisions. MedlinePlus lists fibromyalgia among the uses of duloxetine, milnacipran, and pregabalin. These medicines can cause side effects and need a plan for monitoring and stopping. Pregabalin can cause dizziness or drowsiness; the antidepressants have warnings about suicidal thoughts and behavior in younger people. New or worsening mood symptoms need prompt medical attention.
Bring all medicines and supplements to the discussion. Do not stop prescribed medicines abruptly. Pregnancy, breastfeeding, kidney or liver problems, and medicines prescribed by other clinicians may change the safest option. Your prescriber should explain the risks that matter for you.
How can a longer visit help?
Time lets a clinician map pain, review sleep and concentration, look at prior tests, and check how conditions and medicines interact. It also lets you choose a goal more useful than a pain number alone, such as preparing a meal or getting through a workday. These are tasks a careful visit makes possible, not promised results.
Family medicine can provide a place to bring the pieces together over time. Ask how the practice handles follow-up when symptoms change or the first plan is not helping.
What should you bring and ask at your next visit?
Bring a brief symptom timeline, a list of painful areas, your medicines and supplements, and copies of useful prior results. Include what makes daily life difficult and what you have already tried. You do not need a perfect diary to deserve an assessment.
- Does my pattern fit the diagnostic criteria, and what else needs checking?
- Could another illness be present alongside fibromyalgia?
- Which tests would change the next step, and which can wait?
- What should I do if activity brings delayed or lasting worsening?
- What benefit and side effects should we watch for with a medicine?
- When will we review pain, sleep, and daily function to decide whether the plan helps?
An independent licensed clinician should guide diagnosis and treatment. If you have new or rapidly changing symptoms, ask for a fresh assessment rather than assuming fibromyalgia explains everything.
Frequently asked questions
- Does fibromyalgia require a tender-point exam?
- The 2016 diagnostic criteria use widespread pain, symptom severity, and duration rather than relying on the older tender-point count alone. A physical exam remains part of a clinical assessment.
- Can a rheumatologist diagnose fibromyalgia if I already have arthritis?
- Yes. Another illness does not automatically rule out fibromyalgia under the 2016 criteria. The clinician should assess which symptoms each condition explains.
- Does a normal test mean my pain is not real?
- No. Routine tests may help exclude other causes, but they do not measure everything that contributes to fibromyalgia pain. Your symptoms and their effect on daily life still matter.
Sources
- 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Seminars in Arthritis and Rheumatism, August 30, 2016.
- EULAR revised recommendations for the management of fibromyalgia. Annals of the Rheumatic Diseases, July 4, 2016.
- A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Services Research, April 26, 2010.
- Fibromyalgia. Centers for Disease Control and Prevention, January 25, 2024.
- Pregabalin. MedlinePlus.
- Duloxetine. MedlinePlus.
- Milnacipran. MedlinePlus.
How we write and check these pages: Editorial policy and health review policy. Found a mistake? See our corrections policy.